T Fujitsu

724 total citations
18 papers, 625 citations indexed

About

T Fujitsu is a scholar working on Molecular Biology, Immunology and Transplantation. According to data from OpenAlex, T Fujitsu has authored 18 papers receiving a total of 625 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Molecular Biology, 5 papers in Immunology and 4 papers in Transplantation. Recurrent topics in T Fujitsu's work include Signaling Pathways in Disease (7 papers), Renal Transplantation Outcomes and Treatments (4 papers) and RNA Interference and Gene Delivery (4 papers). T Fujitsu is often cited by papers focused on Signaling Pathways in Disease (7 papers), Renal Transplantation Outcomes and Treatments (4 papers) and RNA Interference and Gene Delivery (4 papers). T Fujitsu collaborates with scholars based in Japan and United States. T Fujitsu's co-authors include Shozo Sakuma, H Fujiwara, H Senoh, Tatsunobu Yoshioka, T Hamaoka, Shigetaka Sugihara, Nobuo Seki, Shinji Sakuma, Yuji Sudo and Toshifumi Shiraga and has published in prestigious journals such as The Journal of Immunology, Biochemical and Biophysical Research Communications and Transplantation.

In The Last Decade

T Fujitsu

18 papers receiving 593 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
T Fujitsu Japan 10 199 165 128 122 114 18 625
Lynne P. Rutzky United States 12 286 1.4× 91 0.6× 261 2.0× 164 1.3× 203 1.8× 18 893
Tatsuaki Morokata Japan 16 113 0.6× 303 1.8× 206 1.6× 69 0.6× 11 0.1× 45 763
John J. Kanalas United States 12 30 0.2× 84 0.5× 252 2.0× 36 0.3× 19 0.2× 24 558
Eva Papp United States 6 99 0.5× 124 0.8× 318 2.5× 49 0.4× 14 0.1× 7 570
B M McManus Canada 11 74 0.4× 162 1.0× 272 2.1× 20 0.2× 8 0.1× 16 744
F. E. Dische United Kingdom 13 55 0.3× 51 0.3× 219 1.7× 15 0.1× 21 0.2× 22 650
Christopher Matheny United States 12 12 0.1× 51 0.3× 109 0.9× 99 0.8× 139 1.2× 23 695
Vera Levytska United States 15 9 0.0× 105 0.6× 307 2.4× 87 0.7× 24 0.2× 17 742
Lorah Perlee United States 13 20 0.1× 179 1.1× 242 1.9× 163 1.3× 15 0.1× 35 684
Roberta Fedele Italy 16 28 0.1× 103 0.6× 207 1.6× 19 0.2× 29 0.3× 47 693

Countries citing papers authored by T Fujitsu

Since Specialization
Citations

This map shows the geographic impact of T Fujitsu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by T Fujitsu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites T Fujitsu more than expected).

Fields of papers citing papers by T Fujitsu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by T Fujitsu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by T Fujitsu. The network helps show where T Fujitsu may publish in the future.

Co-authorship network of co-authors of T Fujitsu

This figure shows the co-authorship network connecting the top 25 collaborators of T Fujitsu. A scholar is included among the top collaborators of T Fujitsu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with T Fujitsu. T Fujitsu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

18 of 18 papers shown
2.
Jiang, Hui‐Rong, et al.. (1999). Inhibition of IL-10 by FK 506 may be responsible for overcoming ongoing allograft rejection in the rat. Transplantation Proceedings. 31(1-2). 1203–1205. 9 indexed citations
3.
Jiang, Hongmei, Shozo Sakuma, Yasutomo Fujii, et al.. (1999). Tacrolimus versus cyclosporin A: a comparative study on rat renal allograft survival. Transplant International. 12(2). 92–99. 20 indexed citations
4.
Jiang, Hongsi, Shozo Sakuma, Yasutomo Fujii, et al.. (1999). Tacrolimus versus cyclosporin A: a comparative study on rat renal allograft survival. Transplant International. 12(2). 92–99. 21 indexed citations
5.
Jiang, Hongsi, T Fujitsu, Kouichi Tamura, et al.. (1995). Immunosuppressive effects of FK 506 on rat renal allograft survival, in comparison with cyclosporine.. PubMed. 27(1). 367–9. 14 indexed citations
6.
Iwasaki, Kenji, Toshifumi Shiraga, Kazuko Nagase, et al.. (1995). Further metabolism of FK506 (tacrolimus). Identification and biological activities of the metabolites oxidized at multiple sites of FK506.. Drug Metabolism and Disposition. 23(1). 28–34. 89 indexed citations
7.
Fujitsu, T, Shozo Sakuma, Yuka Akiyama, et al.. (1994). THE EFFECT OF THE IMMUNOLOGIC MARKER RT2 ON CARDIAC AND RENAL ALLOGRAFT REJECTION IN THE RAT. Transplantation. 58(10). 1137–1138. 9 indexed citations
8.
Tamura, Kouichi, Tsutomu Fujimura, Shinji Sakuma, et al.. (1994). Interaction of Tacrolimus (FK506) and Its Metabolites with FKBP and Calcineurin. Biochemical and Biophysical Research Communications. 202(1). 437–443. 50 indexed citations
9.
Fujitsu, T, Shozo Sakuma, Yuka Akiyama, et al.. (1994). THE EFFECT OF THE IMMUNOLOGIC MARKER RT2 ON CARDIAC AND RENAL ALLOGRAFT REJECTION IN THE RAT. Transplantation. 58(10). 1137–1138. 2 indexed citations
10.
Iwasaki, Kenji, Toshifumi Shiraga, Kazuko Nagase, et al.. (1993). Isolation, identification, and biological activities of oxidative metabolites of FK506, a potent immunosuppressive macrolide lactone.. Drug Metabolism and Disposition. 21(6). 971–977. 88 indexed citations
11.
Taniguchi, K, et al.. (1993). Synthesis and Antiinflammatory and Analgesic Properties of 2-Amino-1H-benzimidazole and 1,2-Dihydro-2-iminocycloheptimidazole Derivatives.. Chemical and Pharmaceutical Bulletin. 41(2). 301–309. 39 indexed citations
12.
Seki, Nobuo, Yuji Sudo, Tatsunobu Yoshioka, et al.. (1988). Type II collagen-induced murine arthritis. I. Induction and perpetuation of arthritis require synergy between humoral and cell-mediated immunity.. The Journal of Immunology. 140(5). 1477–1484. 231 indexed citations
13.
Hiroi, Jun, Kaname Ohara, Katsumasa Kobayashi, et al.. (1988). Effects of FR50948, a new orally active antiallergic agent, in experimental allergic models.. The Japanese Journal of Pharmacology. 46(4). 337–348. 2 indexed citations
14.
Sakuma, Shinya, et al.. (1988). Mechanism of the inhibition of T cell activation by immunosuppressant FK506. International Journal of Immunopharmacology. 10. 108–108. 3 indexed citations
15.
Hirai, Osamu, et al.. (1987). Antitumour Activity of Purified Arabinogalactan-peptidoglycan Complex of the Cell Wall Skeleton of Rhodococcus lentifragmentus. Microbiology. 133(2). 369–373. 7 indexed citations
16.
Fujitsu, T, Shozo Sakuma, Narihito Seki, et al.. (1986). Effect of auranofin on autoimmune disease in a mouse model. International Journal of Immunopharmacology. 8(8). 897–910. 5 indexed citations
17.
Hiroi, Jun, Kaname Ohara, T Fujitsu, et al.. (1985). The anti-inflammatory effect of auranofin.. Folia Pharmacologica Japonica. 86(6). 441–455. 2 indexed citations
18.
Inamura, Noriaki, T Fujitsu, Kunio Nakahara, et al.. (1984). Potentiation of tumoricidal properties of murine macrophages by Nocardia rubra cell wall skeleton (N-CWS). The Journal of Antibiotics. 37(3). 244–252. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026